% IMPORTANT: The following is UTF-8 encoded. This means that in the presence
% of non-ASCII characters, it will not work with BibTeX 0.99 or older.
% Instead, you should use an up-to-date BibTeX implementation like “bibtex8” or
% “biber”.
@ARTICLE{Thierauf:132862,
author = {J. Thierauf and S. E. Weissinger and J. A. Veit and A.
Affolter and N. K. Laureano$^*$ and D. Beutner and G.
Heiduschka and L. Kadletz and M. Meyer and A. Quaas and P.
Plinkert and T. K. Hoffmann and J. Hess$^*$},
title = {{L}ow {SOX}2 expression marks a distinct subset of adenoid
cystic carcinoma of the head and neck and is associated with
an advanced tumor stage.},
journal = {PLoS one},
volume = {13},
number = {3},
issn = {1932-6203},
address = {Lawrence, Kan.},
publisher = {PLoS},
reportid = {DKFZ-2018-00505},
pages = {e0194989 -},
year = {2018},
abstract = {The transcription factor SOX2 has been identified as a
lineage survival oncogene in squamous cell carcinoma and
copy number gain is a common event in several human
malignancies including head and neck cancer. However, the
regulation and function of SOX2 during carcinogenesis as
well as its prognostic value appears to be highly context
dependent. As an example, high SOX2 expression in lung
squamous cell carcinoma (SCC) is related to a favorable
prognosis, while it is associated with poor outcome in lung
adenocarcinoma. More recently, higher SOX2 levels and
improved survival was also reported for head and neck SCC
(HNSCC), and silencing of SOX2 expression in HNSCC cell
lines revealed a mesenchymal-like phenotype with prominent
vimentin expression. So far, SOX2 expression and its
clinical relevance for other head and neck cancers, such as
adenoid cystic carcinoma (HNACC) have not been sufficiently
investigated.SOX2, vimentin and E-cadherin expression was
assessed by immunohistochemical staining on serial sections
from formalin fixed and paraffin embedded tissue samples of
a patient cohort (n = 45) with primary ACC and correlated
with patient and tumor characteristics as well as
survival.High SOX2 expression was found in 14 $(31\%)$
primary tumor specimens and was significantly correlated
with a N0 lymph node status (p = 0.04), while low SOX2
expression was correlated with a solid growth pattern (p =
0.031). Of the 45 patients, 27 tumor samples resembled an
EMT-like phenotype, as assessed by high vimentin and low
E-cadherin levels. However, in HNACC SOX2 levels were
neither correlated with vimentin nor with E-cadherin
expression, further supporting a context dependent
regulation and function of SOX2 in distinct tumor
entities.The absence of SOX2 was predominantly found in
solid HNACC, which are characterized by a more aggressive
phenotype in ACC. However, the underlying molecular
mechanisms of SOX2 regulation and function in distinct HNACC
subgroups remain to be fully elucidated.},
cin = {G405},
ddc = {500},
cid = {I:(DE-He78)G405-20160331},
pnm = {317 - Translational cancer research (POF3-317)},
pid = {G:(DE-HGF)POF3-317},
typ = {PUB:(DE-HGF)16},
pubmed = {pmid:29596469},
pmc = {pmc:PMC5875788},
doi = {10.1371/journal.pone.0194989},
url = {https://inrepo02.dkfz.de/record/132862},
}